Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas usinganti-HBxAgmonoclonal antibody
✍ Scribed by József Pál; Csilla Somogyi; Ágnes Szmolenszky; György Szekeres; József Sípos; Géza Hegedüs; Ilona Martzinovits; János Molnár; Péter Németh
- Book ID
- 105698993
- Publisher
- Springer Netherlands
- Year
- 2001
- Tongue
- English
- Weight
- 786 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1219-4956
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t
Sera of patients from China with hepatocellular carcinoma (HCC) were tested for the presence of HBc/HBe- and HBx antibodies by immunoblotting using recombinant MS2 or beta gal fusion proteins as substrate. Antibodies against HBx were detected in four out of 68 HBsAg positive and in one out of three
The age-specific prevalence of hepatitis B e antigen (HBeAg) and its antibody (anti-HBe) were studied by radioimmunoassay, and compared in a large series of patients with chronic hepatitis B virus (HBV) infection, including 268 asymptomatic carriers, 389 chronic hepatitis, 114 liver cirrhosis, and 2